Abstract
A retrospective study of 56 patients with a basal cell carcinoma of the lid, seen at the Orbital Center between 1981 and 1989, is presented. In 31 patients an eye-saving, histopathologically confirmed, radical excision of the tumor was performed. The patients routinely had an 18-mouth follow-up period for the detection of recurrences. The necessity of this follow-up time after proven radical excision is questioned.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kwitko ML, Boniuk M, Zimmerman LE. Eyelid tumors with reference to lesions confused with squamous cell carcinoma, I: Incidence and errors in diagnosis. Arch Ophthalmol 1963; 69: 53–57.
Henderson JW. Secondary epithelial neoplasms: basal cell carcinoma. In: Henderson JW (ed), Orbital tumors. New York: Decker 1980; 438–446.
Rootman J. Tumors, Secondary tumors of the orbit: basal cell carcinomaof the lid. In: Rootman J (ed), Diseases of the orbit. Philidelphia: JB Lippincoff 1988; 434–437.
Doxanas MT, Green WR, Iliff CE. Factors in the successful surgical management of basal cell carcinoma of the eyelids. Am J Ophthalmol 1981; 91: 726–736.
Suhge d'Aubermont PC, Bennett RG. Failure of curettage and electrodesication for removal of basal cell carcinoma. Arch Dermatol 1984; 120: 1456–1460.
Rowe DE, Caroll RJ, Day CL. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15(3): 315–328.
Epstein E. Value of follow-up after treatment of basal cell carcinoma. Arch Dermatol 1973; 108: 798–800.
Mehta H. Surgical management of carcinoma of eyelids and periorbital skin. Br J Ophthalmol 1979; 63: 578–585.
Mohs FE. Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Opthalmol 1986; 104: 901–909.
Cole JG. Histologically controlled excision of eyelid tumors. Am J Ophthalmol 1970; 70: 240–244.
Frank HJ. Frozen section control of excision of eyelid basal cell carcinoma: 8 1/2 years experience. Br J Ophthalmol 1989; 73: 328–332.
Chalfin J, Puttermans AM. Frozen section control in the surgery of basal cell carcinoma of the eyelid. Am J Ophthalmol 1979; 87: 802–809.
Pascal RR, Hobby LW, Lattes R, Crikelair GF. Prognosis of ‘imcompletely excised’ versus ‘completely excised’ basal cell carcinoma. Plast Reconstruct Surg 1968; 41(4): 328–332.
Older JJ, Quickert MH, Beard C. Surgical removal of basal cell carcinoma of the eyelids utilizing frozen section control. Tr Am Ophth & Otol 1975; 79: 658–663.
Mora RG, Robins P. Basal cell carcinomas in the center of the face: special diagnostic, prognostic, and therapeutic considerations. J Dermatol Surg Oncol 1978; 4(4): 315–321.
Swanson NA. Mohs surgery, technique, indications, applications and the future. Arch Dermatol 1983; 119: 761–773.
Robinson JK. Risk of developing another basal cell carcinoma. A 5-year prospective study. Cancer 1987; 60: 118–20.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tijl, J.W.M., Koornneef, L. The optimal follow-up time for a basal cell carcinoma of the eyelid. Doc Ophthalmol 75, 275–279 (1990). https://doi.org/10.1007/BF00164841
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00164841